Trials / Completed
CompletedNCT02609061
Platelet Rich Fibrin+1% Alendronate in Treatment of Mandibular Degree II Furcation Defects
Platelet Rich Fibrin Combined With 1% Alendronate Gel in Treatment of Mandibular Degree II Furcation Defects: A Randomized Controlled Clinical Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Government Dental College and Research Institute, Bangalore · Academic / Other
- Sex
- All
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The present study was designed to evaluate the combined efficacy of PRF and 1% ALN in the treatment of mandibular degree II furcation defects when compared with PRF and open flap debridement (OFD) alone.
Detailed description
Background: Various regenerative materials have been introduced and tested in the treatment of furcation defects. Platelet-rich fibrin (PRF) is a reservoir of growth factors and cytokines which are the key factors for regeneration of bone and maturation of the soft tissue. Alendronate (ALN), a potent member of bisphosphonate group is known to promote tissue regeneration by inhibiting osteoclastic bone resorption and promoting osteoblastogenesis. The present study was designed to evaluate the combined efficacy of PRF and 1% ALN in the treatment of mandibular degree II furcation defects when compared with PRF and open flap debridement (OFD) alone. Methods: Seventy two mandibular furcation defects were treated with either OFD alone (Group 1), OFD with PRF (Group 2), and OFD with PRF+1% ALN (Group 3). Clinical parameters; site specific plaque index (PI), modified sulcus bleeding index (mSBI), probing depth (PD), relative vertical attachment level (RVAL) and relative horizontal attachment level (RHAL), intrabony defect depth (IBD) were recorded at baseline before surgery and 9 months post-operatively. Percentage radiographic defect fill was evaluated at baseline and 9 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Open flap debridement (OFD) | Open flap debridement (OFD) alone |
| PROCEDURE | OFD with Platelet rich fibrin (PRF) | Open flap debridement (OFD) with Platelet rich fibrin (PRF) placement |
| PROCEDURE | OFD with Platelet rich fibrin (PRF)+1% Alendronate (Drug) in gel form | Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1% Alendronate gel placement |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2015-11-20
- Last updated
- 2015-11-20
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02609061. Inclusion in this directory is not an endorsement.